Medicines Patent Pool
banner
medicinespatentpool.org
Medicines Patent Pool
@medicinespatentpool.org
MPP aims to improve access to affordable #EssentialMedicines – including for treating #HIV #ViralHepatitis #TB #COVID-19 and #NCDs – in low- and middle-income countries through voluntary licensing and technology transfer.
medicinespatentpool.org
MPP provides sustainable solutions that save millions of lives in the short and long run. 🌍 MPP punches well above its weight. 💪

Would you like to explore ways in which we could collaborate? 🤝

Get in touch: medicinespatentpool.org/licensingsav...

#Sustainability #FundingHealthEquity
November 21, 2025 at 8:58 AM
On #WorldChildrensDay, MPP proudly stands as a founding member of GAP-f, driving global collaboration to ensure children everywhere have access to lifesaving medicines.

Learn more: www.who.int/initiatives/...

@pablorojo.bsky.social @sebmoringva.bsky.social
November 20, 2025 at 1:20 PM
Our MPP team will be attending ICASA 2025 in Accra, Ghana 🇬🇭, just two weeks to go!

Feel free to reach out to connect and explore new collaboration opportunities.

Together, we can advance global health.🌍

#ICASA2025 #PublicHealth
@sebmoringva.bsky.social
November 19, 2025 at 2:57 PM
As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶

Together, we continue to advance paediatric HIV care! 🤝
November 18, 2025 at 9:15 AM
On #WorldDiabetesDay, we stand with @who.int’s call: #diabetes affects every life stage. Two inspiring women share their journeys through #pregnancy with #Type1diabetes— highlighting urgent needs for affordable #insulin, tech access, and #education. No one should be left behind.

🔗 bit.ly/3WYVNzB
November 14, 2025 at 3:14 PM
#RSV causes 100,000 child deaths yearly — almost entirely in LMICs. On #WPD, MPP calls for urgent action to make prevention tools like #nirsevimab and #clesrovimab widely accessible, esp. in LMICs.

Voluntary licensing can help close the gap. Learn more: medicinespatentpool.org/story-post/p...
November 13, 2025 at 8:18 AM
Continued and diversified funding is essential for MPP to expand its mandate and future projects. Your contribution can make a significant impact.

Would you like to explore ways in which we could collaborate?
👉 medicinespatentpool.org/licensingsav...

#FundingHealthEquity #GlobalHealth
November 10, 2025 at 4:24 PM
With 🇹🇳 #AORTIC2025 now wrapped up, we want to thank everyone who joined our #MythBuster game at the Medicines Patent Pool booth!

#Oncology professionals, researchers, policymakers, and advocates shared powerful insights about the realities of #cancercare in LMICs.

#AccessToMedicines #HealthEquity
November 7, 2025 at 4:42 PM
At 🇹🇳 #AORTIC2025, our #allwomen panel challenged one of the most persistent misconceptions in access to immuno-oncology in Africa.

✨ Thanks to all the speakers shaping this discussion!
November 4, 2025 at 9:21 AM
🌍 We’re hiring!

The Medicines Patent Pool is looking for:
- Programme Finance Officer
📅 Apply by: 31 October 2025
Learn more 👉 lnkd.in/eTYisnmb

- Consultant / Firm – LAMP Technology Assessment
🗓 Apply by: 3 November 2025
Learn more 👉 lnkd.in/ejkr4nTi
October 24, 2025 at 9:54 AM
🌏 Excited to share that Medicines Patent Pool was invited to the 5th Pharmaceutical Innovation Industry Conference 2025, in Shanghai!

#PharmaInnovation #GlobalHealth #AccessToMedicines
October 24, 2025 at 9:15 AM
🌍 MPP at #CPHIA2025

MPP is pleased to participate in this year’s #CPHIA2025, joining partners to discuss sustainable #localmanufacturing and equitable access to medical products across Africa.

@eburrone.bsky.social - @tiwabraimoh.bsky.social
October 20, 2025 at 8:20 AM
💊 The price of generic TLD (tenofovir, lamivudine, dolutegravir), the WHO-recommended HIV treatment, now costs under $37 per person per year, this has been a game changer in low- and middle-income countries.🌏

🤝 How we can collaborate together: medicinespatentpool.org/licensingsav...
October 15, 2025 at 11:54 AM
Meaningful days in Accra for #AHMTEC2025!

MPP’s Tiwadayo Braimoh and Meghmala Das joined a panel on #licensing opportunities for African manufacturing, showcasing how the MPP model supports access to essential health products and builds sustainable manufacturing capacity across #Africa.
October 13, 2025 at 11:25 AM
🌍 We’re hiring!

The Medicines Patent Pool is looking for a Programme Finance Officer to join our team in Geneva, Switzerland.

📅 Apply by: 31 October 2025
📧 Send your application to: recruitment@medicinespatentpool.org

Learn more 👉 medicinespatentpool.org/call-for-app...
October 9, 2025 at 12:35 PM
MPP and the Vizuri Health Dynamics Foundation are partnering to strengthen #local pharmaceutical #manufacturing and improve access to essential medicines in LMICs.

👉 medicinespatentpool.org/story-post/m...
October 6, 2025 at 9:37 AM
At the UN High-Level Meeting on NCDs and Mental Health, MPP and partners convened a roundtable on expanding access to NCD medicines in LMICs.

Together, we aim to turn commitments into action for equitable, affordable access. 🌍

medicinespatentpool.org/news-publica...
October 3, 2025 at 10:57 AM
Voluntary #LicensingSavesLives by making medicines and health technologies affordable for low- and middle-income countries. 🌍

🤝 But we cannot achieve this great change without your help!

👉 medicinespatentpool.org/licensingsav...
October 1, 2025 at 2:03 PM
Last week, our India and Geneva teams came together for the annual all-staff retreat, a great moment to reflect and plan ahead.☀️ We explored MPP’s future strategy, priorities and ongoing #LicensingSavesLives campaign.

Thank you to all colleagues for your energy, we look forward to what lies ahead!
September 23, 2025 at 9:41 AM
Around 375 patients with #chronicmyeloidleukaemia (CML) in El Salvador, Indonesia & the Philippines are now accessing quality-assured generic #nilotinib.

Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social!

lnkd.in/eruiP-Gv
September 22, 2025 at 1:52 PM
🌍 MPP joined the Joint @who.int @unaids.org @unitaid.bsky.social annual consultation!

Judith Federhofer shared updates on long-acting HIV treatment and the CAB-LA licence amendment for treatment + PrEP. @eburrone.bsky.social discussed access and pricing for #long-acting prevention in LMICs.
September 22, 2025 at 11:44 AM
We’re proud to be recognized in the 2025 Global Health 50/50 Report as a high performer!

MPP’s new Menstrual & Menopause Policy supports women’s health needs through flexible work, awareness & training.

Read more: global5050.org/2025-report/
September 17, 2025 at 1:14 PM
MPP welcomes the updated @who.int Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc).

We remain committed to enabling #access to essential medicines through #voluntarylicensing, #technologytransfer, and #manufacturing support.

👉 lnkd.in/dmr98RHf
September 5, 2025 at 2:26 PM
📢 MPP is looking for a new Expert Advisory Group (EAG) Member!

🗓️ Deadline to apply: 31 August 2025
📩 Apply by sending your CV and cover letter to recruitment@medicinespatentpool.org

More info 👉 medicinespatentpool.org/who-we-are/c...

#Vaccines #AccessToMedicines #PublicHealth #JobOpportunities
August 25, 2025 at 1:22 PM
🌍 Join our mission

📢 Request for Proposals – Feasibility and Concept Design Expert – GMP mRNA Vaccine Manufacturing in Africa

📢 Request for Proposals – GLP1-RA Market Assessment for Obesity Treatment.

📢 Board Member Opportunity

👉 medicinespatentpool.org/who-we-are/c...
August 21, 2025 at 9:25 AM